Free Trial

Crinetics Pharmaceuticals (CRNX) Institutional Ownership

Crinetics Pharmaceuticals logo
$37.35 +0.87 (+2.38%)
As of 01/17/2025 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

Current
Institutional Ownership
Percentage
98.51%
Number of
Institutional Buyers
(last 12 months)
100
Total
Institutional Inflows
(last 12 months)
$617.52M
Number of
Institutional Sellers
(last 12 months)
53
Total
Institutional Outflows
(last 12 months)
$434.81M
Get CRNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crinetics Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CRNX Institutional Buying and Selling by Quarter

Crinetics Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/17/2025Janney Montgomery Scott LLC4,975$254K0.0%+13.7%0.005%
1/17/2025SG Americas Securities LLC542,446$27.74M0.1%+4,084.6%0.585%
1/15/2025 Sanders Morris Harris LLC21,100$1.08M0.2%+13.4%0.023%
1/15/2025 Hennion & Walsh Asset Management Inc.40,090$2.05M0.1%-1.8%0.043%
12/26/2024JPMorgan Chase & Co.285,956$14.61M0.0%+0.3%0.308%
12/19/2024Principal Financial Group Inc.77,709$3.97M0.0%+488.5%0.084%
12/13/2024Lord Abbett & CO. LLC746,118$38.13M0.1%-16.0%0.805%
11/27/2024Franklin Resources Inc.1,390,110$73.82M0.0%+61.4%1.499%
11/16/2024Geode Capital Management LLC1,848,133$94.46M0.0%+10.1%1.993%
11/15/2024Barclays PLC207,712$10.61M0.0%+75.5%0.224%
11/15/2024Pier Capital LLC108,361$5.54M0.8%-0.2%0.117%
11/15/2024Orion Portfolio Solutions LLC18,236$932K0.0%-4.2%0.020%
11/15/2024Castleark Management LLC73,340$3.75M0.2%N/A0.079%
11/15/2024Jane Street Group LLC129,592$6.62M0.0%-4.1%0.140%
11/15/2024Wellington Management Group LLP4,459,691$227.89M0.0%-3.5%4.809%
11/15/2024State Street Corp2,838,484$145.05M0.0%+0.9%3.061%
11/15/2024Stifel Financial Corp10,038$513K0.0%-4.9%0.011%
11/15/2024Point72 Asset Management L.P.2,300,643$117.56M0.3%-17.3%2.481%
11/15/2024Parkman Healthcare Partners LLC77,623$3.97M0.5%-45.1%0.084%
11/15/2024Ikarian Capital LLC426,913$21.82M2.9%-27.5%0.460%
11/15/2024Janus Henderson Group PLC2,429,450$124.13M0.1%-1.1%2.620%
11/15/2024HighVista Strategies LLC28,911$1.48M0.5%-18.0%0.031%
11/15/2024Cinctive Capital Management LP49,445$2.53M0.1%N/A0.053%
11/14/2024Vestal Point Capital LP205,000$10.48M0.8%N/A0.256%
11/14/2024Martingale Asset Management L P22,074$1.13M0.0%N/A0.028%
11/14/2024PEAK6 Investments LLC10,000$511K0.0%+25.0%0.012%
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC271,747$13.89M0.0%+4.1%0.340%
11/14/2024Acuta Capital Partners LLC131,700$6.73M5.5%-2.5%0.165%
11/13/2024Glenmede Trust Co. NA17,144$876K0.0%-4.5%0.021%
11/13/2024BNP Paribas Financial Markets20,942$1.07M0.0%+134.2%0.026%
11/13/2024Advantage Alpha Capital Partners LP8,640$442K0.1%N/A0.011%
11/13/2024FMR LLC4,455,770$227.69M0.0%+8.8%5.567%
11/13/2024The Manufacturers Life Insurance Company134,087$6.85M0.0%+2.3%0.168%
11/13/2024Fisher Asset Management LLC482,099$24.64M0.0%+8.4%0.602%
11/12/2024Algert Global LLC42,777$2.19M0.1%+2.6%0.053%
11/12/2024Valence8 US LP6,684$342K0.1%N/A0.008%
11/12/2024Charles Schwab Investment Management Inc.655,418$33.49M0.0%+9.8%0.819%
11/9/2024Intech Investment Management LLC22,348$1.14M0.0%N/A0.028%
11/8/2024BNP PARIBAS ASSET MANAGEMENT Holding S.A.491,381$25.11M0.1%-10.0%0.614%
11/8/2024Advisors Asset Management Inc.2,806$143K0.0%+56.1%0.004%
11/8/2024Connor Clark & Lunn Investment Management Ltd.20,633$1.05M0.0%+2.5%0.026%
11/8/2024Jennison Associates LLC2,793,614$142.75M0.1%+0.5%3.490%
11/8/2024Commerce Bank4,155$212K0.0%N/A0.005%
11/7/2024First Turn Management LLC353,376$18.06M2.9%-4.3%0.441%
11/7/2024Swiss National Bank130,900$6.69M0.0%+0.5%0.164%
11/6/2024Natixis Advisors LLC44,346$2.27M0.0%+36.6%0.055%
11/6/2024KBC Group NV2,193$112K0.0%+22.8%0.003%
11/6/2024Oppenheimer & Co. Inc.5,469$279K0.0%+16.4%0.007%
11/6/2024Oppenheimer Asset Management Inc.4,216$215K0.0%N/A0.005%
11/5/2024Victory Capital Management Inc.343,344$17.55M0.0%+51.5%0.429%
11/4/2024Lisanti Capital Growth LLC108,575$5.55M1.4%+30.2%0.136%
11/4/2024State of New Jersey Common Pension Fund D37,341$1.91M0.0%-8.0%0.047%
11/1/2024Assetmark Inc.17,147$876K0.0%+13.4%0.021%
11/1/2024Fiera Capital Corp466,075$23.82M0.1%-3.0%0.582%
11/1/2024Lewis Asset Management LLC12,175$622K0.5%-1.8%0.015%
10/31/2024Principal Financial Group Inc.77,709$3.97M0.0%+488.5%0.099%
10/28/2024US Bancorp DE11,488$587K0.0%+3.4%0.015%
10/25/2024China Universal Asset Management Co. Ltd.15,393$787K0.1%+66.1%0.020%
10/25/2024abrdn plc35,467$1.81M0.0%-46.4%0.045%
10/23/2024Mirae Asset Global Investments Co. Ltd.2,895$147K0.0%+23.0%0.004%
10/23/2024Values First Advisors Inc.1,644$84K0.0%N/A0.002%
10/23/2024Moody Aldrich Partners LLC139,130$7.11M1.3%-7.4%0.176%
10/23/2024 Hennion & Walsh Asset Management Inc.40,835$2.09M0.1%-1.2%0.052%
10/19/2024Allspring Global Investments Holdings LLC1,786$91K0.0%N/A0.002%
10/11/2024Creative Planning19,808$1.01M0.0%+52.4%0.025%
10/5/2024Handelsbanken Fonder AB19,000$971K0.0%+15.9%0.024%
10/3/2024SG Americas Securities LLC12,963$662K0.0%-83.6%0.016%
8/20/2024Novo Holdings A S1,000,000$44.79M2.2%-9.0%1.268%
8/20/2024Senator Investment Group LP135,000$6.05M0.3%N/A0.171%
8/19/2024Point72 Asset Management L.P.2,780,856$124.56M0.3%-43.8%3.474%
8/16/2024Creative Planning12,997$582K0.0%+20.6%0.016%
8/16/2024Algert Global LLC41,707$1.87M0.1%+19.0%0.053%
8/16/2024Driehaus Capital Management LLC6,112,173$273.76M2.6%+17.0%7.751%
8/15/2024The Manufacturers Life Insurance Company131,063$5.87M0.0%+21.7%0.166%
8/15/2024Maplelane Capital LLC160,000$7.17M0.2%N/A0.203%
8/15/2024AQR Capital Management LLC7,126$319K0.0%+3.3%0.009%
8/15/2024Affinity Asset Advisors LLC515,000$23.07M2.7%+9.6%0.653%
8/14/2024Squarepoint Ops LLC27,004$1.21M0.0%-21.0%0.034%
8/14/2024Point72 Asset Management L.P.2,780,856$124.56M0.3%-43.8%3.526%
8/14/2024First Light Asset Management LLC1,200,508$53.77M4.7%-29.0%1.522%
8/14/2024Marshall Wace LLP141,204$6.33M0.0%N/A0.179%
8/14/2024Farallon Capital Management LLC497,000$22.26M0.1%+9,840.0%0.630%
8/14/2024Xponance Inc.4,930$221K0.0%N/A0.006%
8/14/2024Integral Health Asset Management LLC400,000$17.92M1.7%+23.1%0.507%
8/14/2024Hood River Capital Management LLC410,342$18.38M0.4%N/A0.520%
8/14/2024HighVista Strategies LLC35,237$1.58M0.6%+121.6%0.045%
8/14/2024ProShare Advisors LLC13,704$614K0.0%-18.1%0.017%
8/14/2024Profund Advisors LLC21,467$962K0.0%-37.4%0.027%
8/13/2024Ensign Peak Advisors Inc616,227$27.60M0.1%-0.8%0.781%
8/13/2024Sei Investments Co.36,973$1.66M0.0%+24.6%0.047%
8/13/2024Public Employees Retirement Association of Colorado9,008$403K0.0%-15.5%0.011%
8/12/2024Resolute Capital Asset Partners LLC30,000$1.34M0.8%+50.0%0.038%
8/12/2024Seven Eight Capital LP8,150$365K0.0%-60.3%0.010%
8/12/2024Hsbc Holdings PLC10,948$478K0.0%+59.2%0.014%
8/12/2024Amalgamated Bank2,692$121K0.0%+20.8%0.003%
8/12/2024E Fund Management Co. Ltd.6,813$305K0.0%-33.5%0.009%
8/9/2024Dimensional Fund Advisors LP546,759$24.49M0.0%-14.7%0.693%
8/8/2024Envestnet Asset Management Inc.51,791$2.32M0.0%+23.5%0.066%
8/8/2024Federated Hermes Inc.15,768$706K0.0%+353.5%0.020%
8/8/2024First Turn Management LLC369,302$16.54M2.7%N/A0.468%
(Data available from 1/1/2016 forward)

CRNX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CRNX shares?

During the previous two years, 156 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals. The most heavily invested institutionals were Driehaus Capital Management LLC ($273.76M), Wellington Management Group LLP ($227.89M), FMR LLC ($227.69M), Price T Rowe Associates Inc. MD ($178.97M), Vanguard Group Inc. ($167.35M), State Street Corp ($145.05M), and Jennison Associates LLC ($142.75M).Learn more on CRNX's institutional investors.

What percentage of Crinetics Pharmaceuticals stock is owned by institutional investors?

98.51% of Crinetics Pharmaceuticals stock is owned by institutional investors. Learn more on CRNX's institutional investor holdings.

Which institutional investors have been buying Crinetics Pharmaceuticals stock?

Of the 136 institutional investors that purchased Crinetics Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($3.47M), Jennison Associates LLC ($2.83M), Janus Henderson Group PLC ($1.43M), FMR LLC ($1.42M), Artal Group S.A. ($1.39M), Driehaus Capital Management LLC ($894.45K), and Wellington Management Group LLP ($869.56K).

How much institutional buying is happening at Crinetics Pharmaceuticals?

Institutional investors have bought a total of 28,540,355 shares in the last 24 months. This purchase volume represents approximately $953.65M in transactions.

Which Crinetics Pharmaceuticals major shareholders have been selling company stock?

Of the 63 institutional investors that sold Crinetics Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Point72 Asset Management L.P. ($5.63M), Perceptive Advisors LLC ($1.62M), Braidwell LP ($1.37M), Frazier Life Sciences Management L.P. ($1.19M), First Light Asset Management LLC ($804.60K), Wellington Management Group LLP ($555.85K), and BNP Paribas Financial Markets ($258.16K).

How much institutional selling is happening at Crinetics Pharmaceuticals?

Institutional investors have sold a total of 13,213,026 shares in the last 24 months. This volume of shares sold represents approximately $492.30M in transactions.



This page (NASDAQ:CRNX) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners